Wetzel Investment Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,000
Closed -$9.48K 131
2024
Q2
$9.48K Hold
6,000
0.01% 466
2024
Q1
$5.39K Buy
6,000
+3,000
+100% +$2.7K ﹤0.01% 662
2023
Q4
$2K Buy
+3,000
New +$2K ﹤0.01% 843